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Abstract
Objective: Valvuloplasty of the aortic valve is currently used in selected patients for severe calcified aortic valve disease, but clinical
effectiveness is low and complication rate remains high. In this study, the total particle load after valvuloplasty and the embolization risk of
calcific debris into the coronary arteries was analyzed in an in vitro model. Methods: Three highly calcified human aortic leaflets have been
sutured into a porcine annulus (N = 9). Both coronary arteries were separated and each was anastomized to a silicon line, which was drained off
into a measuring beaker. Then valvuloplasty was performed (Thyshak II, 20 mm, 1.5 atm). After removal of the balloon, 100 ml of sodium chloride
solution irrigated the ascending aorta. After passing through the separated coronary arteries, the solution was filtered (filter size 0.45 mm), dried,
and the total amount of particles was analyzed microscopically. Results: Nine experiments were analyzed. After valvuloplasty, all hearts showed
a median of 18 particles larger than 1 mm in the coronary arteries (range 0—307). The amount of particles smaller than 1 mm was 6574 (median,
range 2207—14200). In five cases, coronary arteries were completely occluded by bulky particles. Conclusion: This study demonstrated a large
amount of calcific particles after valvuloplasty with a consequently high risk for coronary embolic events in case of highly calcified aortic valves.
In times of valvuloplasty rediscovering as part of transcatheter valve implantation, the risk of embolization should be taken into consideration and
filtering techniques have to be developed.
# 2010 European Association for Cardio-Thoracic Surgery. Published by Elsevier B.V. All rights reserved.
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Calcified aortic valve stenosis is a common disease in the
elderly. The gold standard to treat a symptomatic aortic
valve stenosis is surgical valve replacement. In the past,
valvuloplasty of the aortic valve was used as a bridge to
operation or as a palliative attempt. The outcome after
valvuloplasty was poor when compared with the complica-
tion rate. Common complications are stroke, myocardial
infarction, and aortic dissections. Therefore, the use for
valvuloplasty in clinical routine remains limited [1].
Transcatheter technology for aortic valve implantation led
to a renaissance of valvuloplasty. Different types of valved
stents can be implanted using an antegrade or a retrograde* Corresponding author. Address: Clinic of Cardiac Surgery, University of
Munich — Grosshadern, Marchioninistr. 15, 81377 Munich, Germany.
Tel.: +49 89 7095 2951; fax: +49 89 7095 8898.
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doi:10.1016/j.ejcts.2010.07.045approach [2]. The results of the antegrade approach from
the left-ventricular apex are promising [3]. Valvuloplasty is
obligatory to dilate the native, commonly calcified annulus
before the valved stent can be implanted [4]. Despite the
results of a sole valvuloplasty, there are no data regarding
the amount of particles resulting from the dilation of the
valve.
In this study, the amount of particles that embolized into
the coronary arteries after valvuloplasty was analyzed in an
in vitro model.
2. Material and methods
2.1. Human calcified aortic leaflets
Highly calcified human aortic leaflets were taken from the
operation room. The procedure was approved by the Ethics
Committee of the Christian—Albrechts—University of Kiel
from the 24th of November 2004 (D 434/04).Surgery. Published by Elsevier B.V. All rights reserved.
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Fig. 2. (A) Prepared experimental setup. (B) Insertion of the valvuloplasty
balloon (Thyshak II, +). (C) CT scan of the valvuloplasty balloon (+) during
procedure (* highly calcified human-aortic leaflets).2.2. Valvuloplasty device
For all valvuloplasties, a commercially available valvulo-
plasty balloon Thyshak IIW (NuMED, Inc., New York, USA) with
an outer diameter of 20 mm and a maximum pressure of
1.5 atm was used.
2.3. Experimental setup
To obtain an aortic annulus to analyze the debris rate in
the coronaries after valvuloplasty, nine isolated porcine
hearts (approximately 300 g) were taken from the slaughter-
house. All hearts were prepared as follows: the ascending
aorta was dissected 4 cm distal to the aortic valve. The aortic
diameter was 2.0  0.1 cm (mean  SD). Thereafter, left and
the right stem of the coronary arteries were dissected
approximately 2 cm distal to the coronary ostia (Fig. 1(A)).
Coronary arteries were dissected and subsequently anasto-
mized to a silicon tube with an outer diameter of 2.5 mm,
using a monofil suture (ProleneW 6.0). These 15 cm-long ‘neo-
coronaries’ were drained into ameasuring beaker (Fig. 1(B)).
All three calcified leaflets of one aortic valve were
prepared. Each leaflet was sutured into each coronary sinus
of the native porcine annulus using a running monofil suture
(ProleneW 5.0) (Fig. 1(C)—(E)).
2.4. Valvuloplasty procedure
The heart was fixed in a box (Fig. 2(A)). Then, the
valvuloplasty was performed with a fully inflated Thyshak II
balloon under fluoroscopy and computed tomography (CT)
scan control (Fig. 2(B) and (C)). After removal of the balloon,
irrigation water (saline solution, 0.9%) was administered into
the ascending aorta. This irrigation water could only pass
through the coronaries or the aortic valve into the left
ventricle. However, the water had no possibility to leave the
aorta. The distal aorta was functionally closed. Once 100 ml
saline solution passed the neo-coronaries, the irrigation
water was filtered on a plane filter paper 10 cm in diameter
and a porosity size of 0.45 mm. Thereafter, the filter was
[(Fig._1)TD$FIG]
Fig. 1. (A) Dissection and isolation of both coronary arteries (*: right coronary
artery; **: left coronary artery) in an isolated porcine heart. (B) After isolation
both coronary arteries (*, **) were cut and each anastomized with silicon tubes
(#). (C—E) Then, highly calcified human aortic leaflets (*) were sutured into the
aortic annulus.dried, and the quantity and quality of calcific particles were
microscopically analyzed. The amount of particles was
ordered to 100 ml saline solution.
2.5. Analyzed data
The filter paper was dried and fixed into a Petri dish
(diameter 10 cm). Then, the filter paper was divided into
representative equal pieces. The particles of one piece were
counted using a binocular microscope. Subsequently, the
amount of particles was multiplied with the number of
pieces. The graduation was differentiated in particles
smaller and larger than 1 mm. There was no previous
determination of the debris coming from the left or the
right coronary artery. The data were presented as minimum,
maximum, and median values.
3. Results
All experiments were analyzed. The results of the particles
counted after valvuloplasty are displayed in Fig. 3. In five
cases, a median of 18 particles larger than 1 mm with a range
from 0 to 307 were observed. In all these cases, the coronary
[(Fig._3)TD$FIG]
Fig. 3. The amount of particles in each Petri dish is displayed. In all nine cases,
there were particles smaller than 1 mm observed. Only five experiments
showed particles lager than 1 mm. The scale is logarithmic.
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particles larger than 1 mm were observed. The median of
particles smaller than1 mmwas6574witha range from2207 to
14 200. No major events, such as disruption of the aortic
annulus or dissection of the coronary ostia, were observed
after valvuloplasty.
4. Discussion
There is little known about the occurrence of debris
embolizing into coronary arteries during valvuloplasty of
calcified aortic valves. Literature reported a stroke rate of
1.3—4% [5,6]. In this study, the debris rate in an in vitromodel
with severely calcified aortic valves has been analyzed. The
data show a high number of particles smaller than 1 mm in all
cases. A high number of small particles make sense during
valvuloplasty. However, what happens with these particles in
the clinical setup?
Valvuloplasty is generally carried out during a period of
rapid pacing. With the first heartbeat after this pacing,
approximately, 50—60% of its volume will be flushed in to the
aorta. Suspecting a physical model, low-density particles will
be carried faster into the circulatory system, especially into
the brain. This model matches with the findings of stroke
after valvuloplasty. In most cases, only mild transient
cerebral malfunctions are observed. A current publication
analyses high-intensity transient signals (HITS) in the carotid
arteries during implantation of valved stents [8]. Such
particles were observed in all patients. The highest amount
of microembolic events was detected during valvuloplasty
and positioning of the valved stent in the aortic annulus.
After the procedure, there were no clinical signs of cerebral
ischemia. By contrast, particles with high density will be
more inert with a higher risk of embolization into the
coronary ostia during the first heartbeats. After passing the
aortic arch, embolization into the mesenteric arteries, the
kidneys, and the lower extremities would also be possible.
Our experimental results demonstrated occlusion of the
coronary ostia in five cases. In a clinical setup, myocardial
ischemia up to myocardial infarction may occur [7]. Never-
theless, in the current guidelines of transcatheter valve
implantation, there are no data concerning stroke risk caused
by the valvuloplasty procedure or the subsequent implanta-
tion of the valved stent [4]. In addition, there are no
strategies to avoid the debris problems.
The particles in this study demonstrated the total amount
of particles that will be distributed to the whole body. This
seems to be high, but because there are no other comparable
experimental data, we can only hypothesize about their
impact in the patient. We predict that a large number of
calcified particles will be released during the actual
transcatheter valve stent implantation in highly calcified
aortic valves without post-procedural clinical signs of stroke
or myocardial ischemia. However, ignoring the occurrence of
these particles will not solve the problem, especially in young
patients. To secure the circulatory system from these emboli,
different options have been assessed in the past [9—11].
Unfortunately, currently, there are no valuable filtering
systems for clinical routine used in the actual transapical or
transfemoral procedures. In addition, debris also occursduring the placement of the whole delivery system. In a
recent in vitro study, it could be shown that there are more
plaque ruptures and aortic lesions using a transfemoral
approach [12].
The particles in the in vitro experiments were not
allocated to their origin coronary ostium. It will be important
if the patients’ dorsal position forward the left-main stem
occlusion by particles with higher density [13]. Furthermore,
the results may lead to the assumption that this experimental
model overestimates the number of embolic events in contrast
to the clinical setting. There are two possible explanations:
firstly, the human calcified aortic leaflets were reinserted into
the porcine annulus — a predetermined breaking point can
occur at the suture line and can release more particles during
valvuloplasty. On the other hand, the annular line is the part of
the aortic valve which may be mostly affected by radial stress
during valvuloplasty. If the surface layer of the valve has been
lacerated, calcified debris can be released, too. Secondly, a
100% realistic circulatory situation could not be displayed in
the current model. Therefore, an in vivo model is planned to
evaluate the results of this study in detail.
The identification of calcific debris in the coronary
arteries before and after valvuloplasty and consecutive
valved stent implantation will be advantageous.
Another important point is the rapid-pacing sequence
during valvuloplasty and valve implantation. The necessity of
rapid pacing generates a volumetric overload of the left
ventricle. In case of a severe aortic valve calcification and
stenosis, the left-ventricular myocardium is hypertrophic. An
overexpansion of the myofibrils can result in ventricular
fibrillation and in a significant decrease of the global
ventricular function [14]. Therefore, it will be superior to
avoid any volumetric overload.
The avoidance of extensive valvuloplasty and the
occurrence of obstructive calcified debris might be very
important, if the transcatheter valve-implantation technol-
ogy is to be used in young patients. Therefore, removal of
highly calcified aortic valves will be necessary and has to be
done under safe conditions. The aortic valve isolation
chamber is a preliminary experimental technique to isolate
the aortic valve during resection and implantation of the new
valved stent [15—17].
5. Conclusion
It will be important to develop a system for aortic valve
replacement without an unsecured valvuloplasty under rapid
pacing of the diseased heart muscle to come closer to the
surgical gold standard of aortic valve replacement.
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